Title: Mobile Health Technologies in Inflammatory Bowel Disease: A Narrative Review
Version: 0 Date: 26 Apr 2025
Reviewer's report:
Dear Author,
I am writing regarding your manuscript titled "Mobile Health Technologies in Inflammatory
Bowel Disease: A Narrative Review" submitted to the BMC Gastroenterology for my
consideration as an Invited Reviewer. This is a well-organized, timely, and highly relevant
review considering the increasing integration of digital health solutions in the management of
IBD. The manuscript offers a thorough overview of mobile apps and wearable technologies,
demonstrating a good understanding of the current landscape. I have carefully reviewed your
article and would like to highlight some specific areas for improvement.
Please consider the following points:
1. While the review extensively covers symptom-tracking apps and remote monitoring, the role
of telenutrition is not discussed, despite its growing importance in IBD management.
I recommend including recent advances in telenutrition as a complementary digital health
strategy, particularly focusing on dietary interventions and gut health. I suggest citing the
following paper to support this point:
• Co#kun MG, Kolay E, Basaranoglu M. Telenutrition for the management of inflammatory
bowel disease: Benefits, limits, and future perspectives. World Journal of Clinical Cases
2023;11(2):308.
• Elamin, S., & Cohen, J. (2021). Telenutrition for inflammatory bowel disease: a tipping point
for dietary wellness. Crohn's & Colitis 360, 3(2), otab017.
• Gupta, A., Singh, N., Madan, D., Farooqui, M., Singh, N., Thomas, D. M., ... & Ahuja, V.
(2022). Development and validation of a smartphone application for telenutrition in patients
with inflammatory bowel disease. Diagnostics, 12(10), 2482.
• Gupta, A., Singh, N., Kante, B., Madan, D., Farooqui, M., Singh, N., ... & Ahuja, V. (2022).
Development and validation of a digital health platform (IBD NutriCare) for telenutrition in
patients with Inflammatory bowel disease.
2. Add references for applications on “Table 1: List of mobile apps for IBD management and
their target disease population, features, and availability to patients.”
3. The discussion could benefit from a clearer acknowledgment of the limitations of mobile
apps, such as user adherence challenges, digital literacy barriers, insurance coverage variability,
and disparities in access across different populations.
4. The future outlook is generally well articulated; however, a small section highlighting the need
for interdisciplinary digital platforms (integrating gastroenterologists, dietitians, psychologists,
and exercise physiologists into one app) would be visionary and align well with the holistic
management needs of IBD patients.
Thank you for your valuable contribution to the field. I appreciate the effort you have put into
this manuscript, and I look forward to reviewing it after the suggested revisions.
Yours sincerely,
Title: Mobile Health Technologies in Inflammatory Bowel Disease: A Narrative Review
Version: 0 Date: 26 Apr 2025
Reviewer's report:
Dear Author,
I am writing regarding your manuscript titled "Mobile Health Technologies in Inflammatory
Bowel Disease: A Narrative Review" submitted to the BMC Gastroenterology for my
consideration as an Invited Reviewer. This is a well-organized, timely, and highly relevant
review considering the increasing integration of digital health solutions in the management of
IBD. The manuscript offers a thorough overview of mobile apps and wearable technologies,
demonstrating a good understanding of the current landscape. I have carefully reviewed your
article and would like to highlight some specific areas for improvement.
Please consider the following points:
1. While the review extensively covers symptom-tracking apps and remote monitoring, the role
of telenutrition is not discussed, despite its growing importance in IBD management.
I recommend including recent advances in telenutrition as a complementary digital health
strategy, particularly focusing on dietary interventions and gut health. I suggest citing the
following paper to support this point:
• Co#kun MG, Kolay E, Basaranoglu M. Telenutrition for the management of inflammatory
bowel disease: Benefits, limits, and future perspectives. World Journal of Clinical Cases
2023;11(2):308.
• Elamin, S., & Cohen, J. (2021). Telenutrition for inflammatory bowel disease: a tipping point
for dietary wellness. Crohn's & Colitis 360, 3(2), otab017.
• Gupta, A., Singh, N., Madan, D., Farooqui, M., Singh, N., Thomas, D. M., ... & Ahuja, V.
(2022). Development and validation of a smartphone application for telenutrition in patients
with inflammatory bowel disease. Diagnostics, 12(10), 2482.
• Gupta, A., Singh, N., Kante, B., Madan, D., Farooqui, M., Singh, N., ... & Ahuja, V. (2022).
Development and validation of a digital health platform (IBD NutriCare) for telenutrition in
patients with Inflammatory bowel disease.
2. Add references for applications on “Table 1: List of mobile apps for IBD management and
their target disease population, features, and availability to patients.”
3. The discussion could benefit from a clearer acknowledgment of the limitations of mobile
apps, such as user adherence challenges, digital literacy barriers, insurance coverage variability,
and disparities in access across different populations.
4. The future outlook is generally well articulated; however, a small section highlighting the need
for interdisciplinary digital platforms (integrating gastroenterologists, dietitians, psychologists,
and exercise physiologists into one app) would be visionary and align well with the holistic
management needs of IBD patients.
Thank you for your valuable contribution to the field. I appreciate the effort you have put into
this manuscript, and I look forward to reviewing it after the suggested revisions.
Yours sincerely,
Please review this paper.
user
Title: Mobile Health Technologies in Inflammatory Bowel Disease: A Narrative Review
Version: 0 Date: 26 Apr 2025
Reviewer's report:
Dear Author,
I am writing regarding your manuscript titled "Mobile Health Technologies in Inflammatory
Bowel Disease: A Narrative Review" submitted to the BMC Gastroenterology for my
consideration as an Invited Reviewer. This is a well-organized, timely, and highly relevant
review considering the increasing integration of digital health solutions in the management of
IBD. The manuscript offers a thorough overview of mobile apps and wearable technologies,
demonstrating a good understanding of the current landscape. I have carefully reviewed your
article and would like to highlight some specific areas for improvement.
Please consider the following points:
1. While the review extensively covers symptom-tracking apps and remote monitoring, the role
of telenutrition is not discussed, despite its growing importance in IBD management.
I recommend including recent advances in telenutrition as a complementary digital health
strategy, particularly focusing on dietary interventions and gut health. I suggest citing the
following paper to support this point:
• Co#kun MG, Kolay E, Basaranoglu M. Telenutrition for the management of inflammatory
bowel disease: Benefits, limits, and future perspectives. World Journal of Clinical Cases
2023;11(2):308.
• Elamin, S., & Cohen, J. (2021). Telenutrition for inflammatory bowel disease: a tipping point
for dietary wellness. Crohn's & Colitis 360, 3(2), otab017.
• Gupta, A., Singh, N., Madan, D., Farooqui, M., Singh, N., Thomas, D. M., ... & Ahuja, V.
(2022). Development and validation of a smartphone application for telenutrition in patients
with inflammatory bowel disease. Diagnostics, 12(10), 2482.
• Gupta, A., Singh, N., Kante, B., Madan, D., Farooqui, M., Singh, N., ... & Ahuja, V. (2022).
Development and validation of a digital health platform (IBD NutriCare) for telenutrition in
patients with Inflammatory bowel disease.
2. Add references for applications on “Table 1: List of mobile apps for IBD management and
their target disease population, features, and availability to patients.”
3. The discussion could benefit from a clearer acknowledgment of the limitations of mobile
apps, such as user adherence challenges, digital literacy barriers, insurance coverage variability,
and disparities in access across different populations.
4. The future outlook is generally well articulated; however, a small section highlighting the need
for interdisciplinary digital platforms (integrating gastroenterologists, dietitians, psychologists,
and exercise physiologists into one app) would be visionary and align well with the holistic
management needs of IBD patients.
Thank you for your valuable contribution to the field. I appreciate the effort you have put into
this manuscript, and I look forward to reviewing it after the suggested revisions.
Yours sincerely,
assistant